Here we show that under oxygen -glucose deprivation (OGD), multiple myeloma cells transfer
dysfunctional mitochondria to bone marrow stromal cells (BMSCs) for degradation (transmitophagy).
These mitochondria are then transferred between BMSCs via tunneling nanotubes contributing to
myeloma survival in OGD.
.CC-BY-NC-ND 4.0 International licenseperpetuity. It is made available under a
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
The copyright holder for thisthis version posted October 11, 2024. ; https://doi.org/10.1101/2024.10.08.617234doi: bioRxiv preprint
Multiple myeloma (MM) flourishes within the bone marrow (BM), a metabolically unique
microenvironment with pronounced spatial oxygen-glucose gradients1.
Hypoxia and glucose deprivation drive metabolic reprogramming in MM cells 2, reducing
mitochondrial activity 3,4 while enhancing their reliance on glycolysis via the Warburg effect . This
metabolic shift fuels rapid ATP production and lactate buildup, creating an acidic niche that supports
cancer progression. Targeting oxidative phosphorylation and glycolysis pathways may overcome the
disease evolution, inhibiting the tumor growth in critical ecosystems5.
Consistently, it is known that a cell can transfer functional or non -functional mitochondria to other
cells, contributing to mitochondrial quality control , thereby sustaining cellular plasticity6,7,8,9.
Intercellular mitochondrial tra nsfer in MM, supporting malignant cell survival, was previously
investigated in normoxic co -culture systems, where the transfer of healthy mitochondria from BM
stromal cells (BMSCs) to MM cells was observed10,11.
However, intercellular mitochondrial dynamic occurring under nutrient starvation and hypoxic
conditions mimicking MM microenvironment remain unexplored.
Here, we set up a new co -culture system mirroring the MM niche by co -culturing MM cells and
BMSCs in hypoxic and glucose-serum-deprived environment (0.2% O 2; OGD), identifying a new
mechanism involved in the survival of MM cells.
We found that MM cells survival is sustained by the transcellular degradation of unfunctional
mitochondria, or transmitophagy 12, that are transferred from MM cells to BMSC s, along with an
intercellular transfer of MM cells mitochondria in post-fission state between BMSCs via Tunneling
Nanotubes (TNTs). Notably, when TNTs between BMSCs are destroyed, BMSCs fail to support MM
survival in OGD, highlighting the pivotal role of homotypic TNTs between BMSC s for MM
progression.
JJN3 MM human cell line and BMSCs were cultured under normoxic control conditions (Nx) or in
OGD. Mitochondrial membrane potential (), apoptosis, and TNTs were analyzed (Figure 1A). The
of JJN3 cells was higher compared to that measured for BMSC s, and under OGD conditions,
the of JJN3 cells strongly decreased, while the of BMSCs remained unaffected (Figure 1B).
To mimic the hypoxic MM microenvironment, JJN3 cells were co -cultured with BMSCs under both
normoxic and OGD conditions, and apoptotic cells were measured. In OGD BMSCs were found to
be healthy and able to rescue JJN3 cells from OGD-triggered apoptosis (Figure 1C). Nx and OGD
co-cultures were stained for F -actin and specifically analyzed for TNTs 13,14. It was found that OGD
triggers homotypic TNT formation between BMSC s (Figure 1D), while h eterotypic TNTs between
JJN3 cells and BMSCs were extremely rare. These homotypic TNTs were observed to be detached
from the substrate (Figure 1E), capable of transferring cargo between BMSCs, and were highly
dynamic (Figure 1F).
To trace the intercellular dynamics of JJN3 mitochondria, JJN3 cells were stained for mitochondria
using the fixable Mitotracker Deep Red (JJN3 Mito) and co-cultured with BMSCs under Nx or OGD
conditions. The cells were then analyzed by confocal microscopy to determine JJN3 mitochondrial
localization (Figure 2A). Confocal microscopy revealed the presence of JJN3 mitochondria inside
BMSCs. Under OGD conditions, the intercellular transfer of mitochondria increased, and the size of
the transferred mitochondria was smaller compared to Nx, indicating that OGD triggers the transfer
of mitochondria from JJN3 cells to BMSCs and that in OGD JJN3 mitochondria inside BMSCs were
in a post-fission state (Figure 2B).
Analysis of gap junction protein Connexin 43 (Cx43) localization revealed that JJN3 cells were in
direct contact with BMSCs via CX43 junctions, and JJN3 mitochondria appeared to be internalized
by BMSCs through these CX43 junctions (Figure 2C), suggesting a CX43 -dependent intercellular
mitochondrial transfer8. Heterotypic TNTs between JJN3 cells and BMSCs were extremely rare, and
no mitochondria were found inside them.
We further analyzed the co-culture for lysosomal-associated membrane protein 1 (Lamp1). Confocal
microscopy clearly showed JJN3 mitochondria inside BMSCs interacting with Lamp1, with enhanced
colocalization under OGD conditions. A more detailed analysis of JJN3 mitochondrial and L amp1
localization and morphology in BMSCs revealed that, under OGD conditions, large masses of JJN3
mitochondria appeared to be internalized by BMSCs within an actin cage, surrounded by L amp1,
which is typical of damaged mitochondria destined for mitophagy15 (Figure 2D, central panel).
Once inside BMSCs, multiple mitochondria-Lamp1 contacts were observed, and fission points were
identified in JJN3 mitochondria (Figure 2D, bottom panel, white arrows). Notably, lysosomal contacts
.CC-BY-NC-ND 4.0 International licenseperpetuity. It is made available under a
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
The copyright holder for thisthis version posted October 11, 2024. ; https://doi.org/10.1101/2024.10.08.617234doi: bioRxiv preprint
mark the sites of mitochondrial fission 16. Since JJN3 mitochondria lose membrane potential under
OGD, a well-known trigger for mitophagy17,18, and various signs of fission appear in BMSCs for JJN3
mitochondria, we conclude that JJN3-to-BMSCs transmitophagy12,15 occurs under OGD conditions.
We analyzed TNTs between BMSCs under OGD conditions for the presence of JJN3 mitochondria
and Lamp1 localization. The analysis revealed that the homotypic TNT s network between BMSCs
contains small JJN3 mitochondria in a post-fission state, along with Lamp1 (Figure 2E, inset a), and
punctate JJN3 mitochondria interacting with Lamp1 (Figure 2E, inset b).
To assess whether TNTs between BMSCs can transfer these mitochondria between BMSCs, we co-
cultured BMSC s with JJN3 mitochondria under OGD for 24 hours and washed out JJN3 cells,
generating donor BMSCs(JJN3 Mito). Subsequently, donor BMSCs(JJN3 Mito) were incubated with acceptor
BMSCs stained with DiI under OGD conditions. We found that donor BMSCs(JJN3 Mito) were connected
to acceptor BMSC s via TNTs containing JJN3 mitochondria in post -fission state and these
mitochondria localize in acceptor BMSCs. These findings demonstrate that TNTs between BMSCs
can transfer small JJN3 mitochondria in post-fission state between BMSCs (Figure 2F).
To test whether TNTs between BMSC s play a functional role in protecting JJN3 cells from OGD-
triggered apoptosis, we disrupted the TNTs network between BMSCs in OGD using Cytochalasin-D
(CytoD), a well-known drug that disrupts TNTs9. After washing out CytoD, we co-cultured CytoD pre-
treated BMSCs with JJN3 cells under OGD conditions. Analysis of TNTs and cell apoptosis revealed
that pre-treatment with CytoD destroy TNTs network between BMSCs (Figure 2G) and prevent the
rescue of JJN3 cells from OGD-triggered apoptosis (Figure 2H). Taken together, our data show that
the TNT s network between BMSC s allows the intercellular transfer of post -fission JJN3
mitochondria, supporting JJN3-to-BMSCs transmitophagy and contributing to the survival of JJN3
cells in the hypoxic MM niche (Figure 2I).
Our findings uncover a crucial metabolic adaptation in MM: we show that in a co -culture system
mimicking the hypoxic MM milieu, the of MM cells is strongly affected and, most interestingly,
these mitochondria are transferred to BMSCs for fission (transmitophagy). This mechanism has
primarily been described in the central nervous system and has not been shown before in
cancer12,19,20. Furthermore, in this context, BMSCs support MM cells survival by generating an active
TNTs network among themselves for the transfer of MM mitochondria in a post -fission state,
facilitating efficient transmitophagy within the BMSCs population. To the best of our knowledge, this
is the first evidence of concerting role for transmitophagy and a TNT s network in the OGD MM
microenvironment. Undeniably, treatments targeting oxidative phosphorylation, such as proteasome
inhibitors are known to in duce endoplasmic reticulum stress and apoptosis in MM cells 21. Hence,
resistance mechanisms driven by mitochondrial adaptations highlight the importance of metabolic
plasticity. The quiescent MM cells, which are resistant to standard and novel agents, could correlate
with metabolic shift sustaining the minimal residual disease in OGD22,23.
Overall, preventing TNT s-mediated intercellular mitochondrial exchange could weaken the
protective environment that BMSCs provide to MM cells. This could represent a new frontier in MM
therapy focused on metabolic vulnerabilities.
.CC-BY-NC-ND 4.0 International licenseperpetuity. It is made available under a
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
The copyright holder for thisthis version posted October 11, 2024. ; https://doi.org/10.1101/2024.10.08.617234doi: bioRxiv preprint
Acknowledgments
This work was supported by by Unione Europea “National Center for Gene Therapy and Drugs based
on RNA Technology" , PNRR missione 4 – componente 2 – investimento 1.4 , cod.prog.
CN00000041- CUP H93C22000430007” to F.P. and A.G.S and by the “Fondo per il Programma
Nazionale di Ricerca e Progetti di Rilevante Interesse Nazionale —PRIN” (project n.2022ZKKWLW
to A.G.S.). A.G.S. was also supported by a grant from “Società Italiana di Medicina Interna—SIMI”
2023 Research Award (CAMEL).
The graphical abstract and Figures 1A, 2A, and 2I were created with BioRender:
BioRender.com/w13y615, Agreement number YH27EBHZVD.
Authorship
Contribution: F.P., A.G.S., designed the research; F.D.P., V.D., F.P., and A .G.S. performed the
experiments; all authors were involved in the analysis and interpretation of the data; A.G.S., F.P.,
F.D.P. and V.D. wrote the manuscript; F.P., A.V. and M.S. supervised the research and revised the
manuscript. A.G.S. obtained the informed consent and obtained the primary samples. F.P. and
A.G.S. financially supported the research. All authors approved the manuscript.
Conflict-of-interest disclosure: The authors declare no competing financial interests.
ORCID profiles: A.G.S. 0000-0002-2293-9698; V.D. 0000-0003-1942-2601; A.V. 0000-0002-4567-
8216, M.S. 0000-0002-5584-9541, F.P. 0000-0001-8511-117X
Footnotes
*A.G.S. and F.D.P contributed equally to this study as first authors.
#Correspondence: Francesco Pisani Department of Bioscience, Biotechnology and
Biopharmaceutics, University of Bari Aldo Moro, Bari, Italy., e-mail:
[email protected]
.CC-BY-NC-ND 4.0 International licenseperpetuity. It is made available under a
preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in
The copyright holder for thisthis version posted October 11, 2024. ; https://doi.org/10.1101/2024.10.08.617234doi: bioRxiv preprint